ARTEMIDA Trial (A Randomized Trial of Efficacy, 12 Months International Double-Blind Actovegin): A Randomized Controlled Trial to Assess the Efficacy of Actovegin in Poststroke Cognitive Impairment

BACKGROUND AND PURPOSE—: Poststroke cognitive impairment is a debilitating consequence of stroke. The aim of this study was to assess whether Actovegin confers cognitive benefit in patients who have had an ischemic stroke. METHODS—: This was a 12-month, parallel-group, randomized, multicenter, doubl...

Descripción completa

Detalles Bibliográficos
Autores principales: Guekht, Alla, Skoog, Ingmar, Edmundson, Sally, Zakharov, Vladimir, Korczyn, Amos D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2017
Materias:
Original Contributions
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5404405/
https://www.ncbi.nlm.nih.gov/pubmed/28432265
http://dx.doi.org/10.1161/STROKEAHA.116.014321

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5404405/
https://www.ncbi.nlm.nih.gov/pubmed/28432265
http://dx.doi.org/10.1161/STROKEAHA.116.014321

Ejemplares similares